Thornburg Investment Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.04M Sell
618,857
-192,891
-24% -$2.55M 0.09% 78
2026
Q1
$11.2M Buy
811,748
+371,124
+84% +$5.59M 0.12% 79
2025
Q4
$7.94M Buy
+440,624
New +$7.91M 0.1% 94

Other funds holding CLBT

Thornburg Investment Management's CLBT Position: Q2 2026 in Review

Thornburg Investment Management reduced its Cellebrite (CLBT) stake by 24% in Q2 2026, selling an estimated $2.55M and leaving 618,857 shares worth $9.04M. The position accounts for 0.09% of the portfolio, ranked #78.

Thornburg Investment Management first reported a position in CLBT in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.2M in Q1 2026. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Thornburg Investment Management held 618,857 shares of Cellebrite worth $9.04M as of Q2 2026.
  • Thornburg Investment Management sold 192,891 Cellebrite shares in Q2 2026, an estimated $2.55M.
  • Cellebrite made up 0.09% of Thornburg Investment Management's portfolio in Q2 2026, its #78 holding.
  • Thornburg Investment Management first reported a position in Cellebrite in Q4 2025 and has held it in 3 quarters since.
  • Thornburg Investment Management's Cellebrite position peaked at $11.2M in Q1 2026.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Thornburg Investment Management's 13F filing for Q2 2026, filed 13 Aug 2026.